Browse > Article
http://dx.doi.org/10.7318/KJFC/2020.35.2.224

Fatty Acid Concentration of Serum Phospholipids in Normal and Glaucoma Patients  

Chung, Hae-Yun (Department of Food and Nutrition, Soongeui Women's College)
Publication Information
Journal of the Korean Society of Food Culture / v.35, no.2, 2020 , pp. 224-232 More about this Journal
Abstract
Glaucoma is one of the leading causes of blindness worldwide and is characterized by degeneration of the optic nerve. Elevated intraocular pressure (IOP) is the major contributing factor to optic nerve damage. However, some patients develop glaucoma even with normal IOP. Other factors, including age, race, myopia, and nutrition, can affect glaucoma risk. Dietary fat intake and serum fatty acid composition are closely related with the fatty acid profile of the retina and thus can modulate glaucoma risk. In this study, we collected serum samples from 34 glaucoma patients (26 primary open angle glaucoma (POAG) and 8 normal tension glaucoma (NTG)) and 45 healthy controls and analyzed their serum phospholipid fatty acid concentrations. The results show that the ratio of oleic acid to stearic acid (OA/SA), which is an indicator of stearoyl-CoA desaturase activity, was higher in POAG patients when compared to normal controls. The ratio of eicosapentaenoic acid to arachidonic acid (EPA/AA), which is an indirect marker of eicosanoid biosynthesis, was also higher in glaucoma patients (p=0.048). These results imply that dietary fatty acid intake and serum fatty acid profile can influence glaucoma risk. Additional study is necessary to identify the relationship between fatty acids and glaucoma.
Keywords
Glaucoma; serum phospholipid; fatty acids;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hoffman DR, Boettcher JA, Diersen-Schade DA. 2009. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins Leukot. Essent. Fatty Acids, 81(2-3):151-158   DOI
2 Innis SM. 1996. Essential dietary lipids. In: Ziegler EE, Filer LJ, eds. Present knowledge in nutrition. 7th ed. ILSI Press, Washington, DC, USA, pp 58-66
3 Innis SM. 2008. Dietary omega 3 fatty acids and the developing brain. Brain Res., 1237:35-43   DOI
4 Innis SM, Dyer RA. 2002. Brain astrocyte synthesis of docosahexaenoic acid from n-3 fatty acids is limited at the elongation of docosapentaenoic acid. J. Lipid Res., 43(9):1529-1536   DOI
5 James MJ, Gibson RA, Cleland LG. 2000. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr., 71(1suppl):343S-348S   DOI
6 Kang JH, Pasquale LR, Willett WC, Rosner BA, Egan KM, Faberowski N, Hankinson SE. 2004. Dietary fat consumption and primary open-angle glaucoma. Am. J. Clin. Nutr., 79(5):755-764   DOI
7 Kris-Etherton PM, Harris WS, Appel LJ. 2002. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 106(21):2747-2757   DOI
8 Lee BL, Bathija R, Weinreb RN. 1998. The definition of normal-tension glaucoma. J. Glaucoma, 7(6):366-371
9 McMonnies CW. 2017. Glaucoma history and risk factors. J. Optom., 10(2):71-78   DOI
10 Merle BM, Benlian P, Puche N, Bassols A, Delcourt C, Souied EH; Nutritional AMD Treatment 2 Study Group. 2014. Circulating omega-3 Fatty acids and neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 55(3):2010-2019   DOI
11 Quigley HA, Broman AT. 2006. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol., 90(3):262-267   DOI
12 Mozaffarieh M, Flammer J. 2007. A novel perspective on natural therapeutic approaches in glaucoma therapy. Expert. Opin. Emerg. Drugs, 12(2):195-198   DOI
13 Nucci C, Russo R, Martucci A, Giannini C, Garaci F, Floris R, Bagetta G, Morrone LA. 2016. New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system. Eur. J. Pharmacol., 787:119-126   DOI
14 Paton CM, Ntambi JM. 2009. Biochemical and physiological function of stearoyl-CoA desaturase. Am. J. Physiol. Endocrinol. Metab., 297(1):E28-E37   DOI
15 Pelletier AL, Rojas-Roldan L, Coffin J. 2016. Vision loss in older adults. Am. Fam. Physician, 94(3):219-226
16 Prez de Arcelus M, Toledo E, Martnez-Gonzlez M, Sayn-Orea C, Gea A, Moreno-Montas J. 2014. Omega 3:6 ratio intake and incidence of glaucoma: the SUN cohort. Clin. Nutr., 33(6):1041-1045   DOI
17 Ramdas WD. 2018. The relation between dietary intake and glaucoma: a systematic review. Acta. Ophthalmol., 96(6):550-556   DOI
18 Ramdas WD, Wolfs RC, Kiefte-de Jong JC, Hofman A, de Jong PT, Vingerling JR, Jansonius NM. 2012. Nutrient intake and risk of open-angle glaucoma: the Rotterdam Study. Eur. J. Epidemiol., 27(5):385-393   DOI
19 Ren H, Magulike N, Ghebremeskel K, Crawford M. 2006. Primary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acids. Prostaglandins Leukot. Essent. Fatty Acids, 74(3):157-163   DOI
20 Renard JP, Rouland JF, Bron A, Sellem E, Nordmann JP, Baudouin C, Denis P, Villain M, Chaine G, Colin J, de Pouvourville G, Pinchinat S, Moore N, Estephan M, Delcourt C. 2013. Nutritional, lifestyle and environmental factors in ocular hypertension and primary open-angle glaucoma: an exploratory case-control study. Acta. Ophthalmol., 91(6):505-513   DOI
21 Resch H, Garhofer G, Fuchsjager-Mayrl G, Hommer A, Schmetterer L. 2009. Endothelial dysfunction in glaucoma. Acta. Ophthalmol., 87(1):4-12   DOI
22 Simopoulos AP. 2008. The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease. Asia Pac J Clin Nutr., 17 Suppl 1:131-134
23 SanGiovanni JP, Chew EY. 2005. The role of omega-3 longchain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye Res., 24(1):87-138   DOI
24 Semenova EM, Converse CA. 2003. Comparison between oleic acid and docosahexaenoic acid binding to interphotoreceptor retinoid-binding protein. Vision Res., 43(28):3063-3067   DOI
25 Seo SJ, Lee YH, Lee SY, Bae HW, Hong S, Seong GJ, Kim CY. 2016. Estimated prevalence of glaucoma in South Korea using the national claims database. J. Ophthalmol., 2016:1690256
26 Stjernschantz JW. 2001. From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of Xalatan. Invest. Ophthalmol. Vis. Sci., 42(6):1134-1145
27 Thibaut AC, Rotival M, Gauthier E, Lenoir GM, Boutron-Ruault MC, Joulin V, Clavel-Chapelon F, Chajs V. 2009. Correlation between serum phospholipid fatty acids and dietary intakes assessed a few years earlier. Nutr. Cancer, 61(4):500-509   DOI
28 Varma R, Ying-Lai M, Francis BA, Nguyen BB, Deneen J, Wilson MR, Azen SP; Los Angeles Latino Eye Study Group. 2004. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology, 111(8):1439-1448   DOI
29 Korea ministry of health & welfare. 2015 KDRIs, Dietary reference intakes for Koreans. Available from: http://www.korea.kr, [accessed 2020.2.1]
30 Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. 2002. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol. Aging, 23(5):843-853   DOI
31 Weinreb RN, Aung T, Medeiros FA. 2014. The pathophysiology and treatment of glaucoma: a review. JAMA, 311(18):1901-1911   DOI
32 Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH. 2008. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch. Ophthalmol., 126(6):826-833   DOI
33 Acar N, Berdeaux O, Grgoire S, Cabaret S, Martine L, Gain P, Thuret G, Creuzot-Garcher CP, Bron AM, Bretillon L. 2012. Lipid composition of the human eye: are red blood cells a good mirror of retinal and optic nerve fatty acids? PLoS One, 7(4):e35102   DOI
34 Baylin A, Campos H. 2006. The use of fatty acid biomarkers to reflect dietary intake. Curr. Opin. Lipidol., 17(1):22-27   DOI
35 Cho HK, Kee C. 2014. Population-based glaucoma prevalence studies in Asians. Surv. Ophthalmol., 59(4):434-447   DOI
36 Folch J, Ascoli I, Lee SM, Meath JA, LeBaron N. 1951. Preparation of lipide extracts from brain tissue. J. Biol. Chem., 191(2):833-841   DOI
37 Fanning S, Haque A, Imberdis T, Baru V, Barrasa MI, Nuber S, Termine D, Ramalingam N, Ho GPH, Noble T, Sandoe J, Lou Y, Landgraf D, Freyzon Y, Newby G, Soldner F, Terry-Kantor E, Kim TE, Hofbauer HF, Becuwe M, Jaenisch R, Pincus D, Clish CB, Walther TC, Farese RV Jr, Srinivasan S, Welte MA, Kohlwein SD, Dettmer U, Lindquist S, Selkoe D. 2019. Lipidomic analysis of ${\alpha}$-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for parkinson treatment. Mol. Cell, 73(5):1001-1014   DOI
38 Faralli JA, Filla MS, Peters DM. 2019. Role of fibronectin in primary open angle glaucoma. Cells, 8(12). pii: E1518
39 Flammer J, Orgl S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, Stefnsson E. 2002. The impact of ocular blood flow in glaucoma. Prog. Retin. Eye Res., 21(4):359-393   DOI
40 Fliesler SJ, Anderson RE. 1983. Chemistry and metabolism of lipids in the vertebrate retina. Prog. Lipid Res., 22(2):79-131   DOI
41 Greiner CA, Greiner JV, Leahy CD, Auerbach DB, Marcus MD, Davies LH, Rodriguez W, Glonek T. 1995. Distribution of membrane phospholipids in the rabbit neural retina, optic nerve head and optic nerve. Int. J. Biochem. Cell Biol., 27(1):21-28   DOI
42 Heintz N, Zoghbi H. 1997. alpha-Synuclein--a link between Parkinson and Alzheimer diseases? Nat. Genet., 16(4):325-327   DOI
43 Higginbotham EJ, Gordon MO, Beiser JA, Drake MV, Bennett GR, Wilson MR, Kass MA; Ocular Hypertension Treatment Study Group. 2004. The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals. Arch. Ophthalmol., 122(6):813-820   DOI